Adverse Event Reporting News - Tegretol carries risk of serious skin conditions in Asian patients
Sunday, January 11th, 2009 Novartis Pharmaceuticals Canada, following discussion with Health Canada, has revised its Product Monograph for Tegretol (carbamazepine) to include in the WARNINGS section information about the risks of Toxic Epidermal Necrolysis (TEN) and Stevens-Johnson Syndrome (SJS), particularly in patients of Asian descent.
Both conditions involve serious and sometimes fatal dermatologic reactions. The risk of SJS and TEN exists in all patients, but these reactions are genera…
